In conclusion, within the limitations of the present study, non-surgical treatment with an EYL for PID was clinically effective and may associated with reducing peri-implant tissue destruction through decreased MMP-9 levels in PICF. This evidence concerns the gene MMP9 and pelvic inflammatory disease.